<i>Clinical trial designs of emerging therapies for DKD</i>Clinical trial designs of emerging therapies for diabetic kidney disease (DKD).
糖尿病腎病 (DKD) 新興療法的臨床試驗設計。
Postgrad Med 2024-07-24
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
非糖尿病慢性腎臟病患者中Finerenone與標準治療聯合應用對腎臟疾病進展的影響(FIND-CKD)隨機試驗的設計和基線特徵。
Nephrol Dial Transplant 2024-06-11
Investigational new drugs for the treatment of chronic renal failure: an overview of the literature.
慢性腎衰竭治療的新研究藥物:文獻總覽。
Expert Opin Investig Drugs 2024-04-08
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
慢性腎臟病的醛固酮合成酶抑制及是否搭配 empagliflozin 的療效和安全性:一項隨機、對照的2期試驗。
Lancet 2024-02-01
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
Zibotentan與dapagliflozin組合藥物與單獨dapagliflozin在慢性腎臟病患者中的比較(ZENITH-CKD):一項多中心、隨機、主動對照、2b期臨床試驗。
Lancet 2023-12-12
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
Zibotentan和dapagliflozin在慢性腎臟病患者中的療效和安全性:ZENITH-CKD試驗的研究設計和基線特徵。
Nephrol Dial Transplant 2024-03-07
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
糖尿病腎病患者中間質幹細胞(ORBCEL-M)治療的安全性和初步療效:一項隨機臨床試驗(NEPHSTROM)。
J Am Soc Nephrol 2024-03-05
Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.
第二型糖尿病和慢性腎病患者中添加補腎劑六味地黃丸的中醫藥:多中心隨機對照試驗。
Clin J Am Soc Nephrol 2023-10-12